£108.78

Springer Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)

Price data last checked 10 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 81 days • 81 data points (No recent data available)

Historical
Generating forecast...
£109.64 £108.69 £108.90 £109.11 £109.31 £109.52 £109.73 24 January 2026 13 February 2026 05 March 2026 25 March 2026 14 April 2026

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price
Current Price
1 day · current 80 days 0 20 40 60 80 £109 £110 Days at Price

Price Analysis

Most common price: £110 (80 days, 98.8%)

Price range: £109 - £110

Price levels: 2 different prices over 81 days

Description

Product Description This book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine.   Review “This book examines the ‘translational gap’ between animal models of neuropsychiatric disease and human studies. … The intended audience is scientists working on problems related to neuropsychopharmacology. … This is an important addition to the literature on translational neurosciences. It is an important contribution to understanding both the current state of this field and its possible future directions.” (Eric Gausche, Doody's Book Reviews, November, 2016) From the Back Cover This book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
98% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£141.86 16 Apr 2026
Psychiatric Aspects Of Neurologic Diseases: Practical Approaches to Patient Care
98% match

Psychiatric Aspects Of Neurologic Diseases: Practical Approaches to Patient Care

Oxford University Press

£24.54 15 Apr 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
98% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.44 05 Apr 2026
Drug Development in Psychiatry: 30 (Advances in Neurobiology, 30)
98% match

Drug Development in Psychiatry: 30 (Advances in Neurobiology, 30)

Springer

£154.66 17 Apr 2026
Molecular and Functional Models in Neuropsychiatry: 7 (Current Topics in Behavioral Neurosciences, 7)
98% match

Molecular and Functional Models in Neuropsychiatry: 7 (Current Topics in Behavioral Neurosciences, 7)

Springer

£110.00 31 Mar 2026
An Outline of Psychiatry in Clinical Lectures: The Lectures of Carl Wernicke
98% match

An Outline of Psychiatry in Clinical Lectures: The Lectures of Carl Wernicke

Springer

£86.01 05 Apr 2026
Neurobehavioral Toxicology: Neurological and Neuropsychological Perspectives, Volume III: Central Nervous System: 3 (Studies on Neuropsychology, Neurology and Cognition)
98% match

Neurobehavioral Toxicology: Neurological and Neuropsychological Perspectives, Volume III: Central Nervous System: 3 (Studies on Neuropsychology, Neurology and Cognition)

Taylor & Francis

£124.73 21 Apr 2026
Neuroscience for the Mental Health Clinician, Second Edition
98% match

Neuroscience for the Mental Health Clinician, Second Edition

The Guilford Press

£61.93 20 Apr 2026
Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)
98% match

Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)

Humana

£99.99 18 Apr 2026
Advances in Neuroscience, Neuropsychiatry, and Neurology
98% match

Advances in Neuroscience, Neuropsychiatry, and Neurology

£352.00 14 Apr 2026
Cultural Patterns And Neurocognitive Circuits II: East-West Connections: 5 (Exploring Complexity)
98% match

Cultural Patterns And Neurocognitive Circuits II: East-West Connections: 5 (Exploring Complexity)

Scientific Publishing

£57.99 30 Mar 2026
Modern CNS Drug Discovery: Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval
98% match

Modern CNS Drug Discovery: Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval

Springer

£59.47 11 Apr 2026
Neuroinformatics: 401 (Methods in Molecular Biology, 401)
98% match

Neuroinformatics: 401 (Methods in Molecular Biology, 401)

Humana

£79.44 02 Apr 2026
Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment
98% match

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Springer

£108.78 15 Apr 2026
Psychiatry and Neuroscience Update: From Epistemology to Clinical Psychiatry – Vol. IV
98% match

Psychiatry and Neuroscience Update: From Epistemology to Clinical Psychiatry – Vol. IV

Springer

£126.33 16 Apr 2026
Cognitive Neuropsychology and Language Rehabilitation: A Special Issue of Neuropsychological Rehabilitation: 1
98% match

Cognitive Neuropsychology and Language Rehabilitation: A Special Issue of Neuropsychological Rehabilitation: 1

Routledge

£43.19 12 Mar 2026
Behavioral Neurogenomics: 42 (Current Topics in Behavioral Neurosciences, 42)
98% match

Behavioral Neurogenomics: 42 (Current Topics in Behavioral Neurosciences, 42)

Springer

£99.71 18 Apr 2026
Atoms of Mind: The "Ghost in the Machine" Materializes
98% match

Atoms of Mind: The "Ghost in the Machine" Materializes

Springer

£113.63 15 Apr 2026
Neuroscience for the Mental Health Clinician, Second Edition
98% match

Neuroscience for the Mental Health Clinician, Second Edition

The Guilford Press

£40.99 20 Apr 2026
Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)
98% match

Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)

Springer

£107.73 09 Apr 2026
The Plastic Brain: 1015 (Advances in Experimental Medicine and Biology, 1015)
98% match

The Plastic Brain: 1015 (Advances in Experimental Medicine and Biology, 1015)

Springer

£113.03 31 Mar 2026
Molecular Neuropharmacology: Strategies and Methods
98% match

Molecular Neuropharmacology: Strategies and Methods

Humana

£124.98 31 Mar 2026
Big Data in Psychiatry and Neurology
98% match

Big Data in Psychiatry and Neurology

Academic Press

£101.49 30 Mar 2026
Psychopharmacologie essentielle. Bases neuroscientifiques et applications pratiques (4° Éd.)
98% match

Psychopharmacologie essentielle. Bases neuroscientifiques et applications pratiques (4° Éd.)

£114.70 19 Apr 2026